Ännu en UFC-fighter har åkt fast för dopning. Denna gång är det den ryske lättviktaren Mairbek Taisumov (28-5 MMA, 7-1 UFC) som testat positivt för det otillåtna ämnet stanozolol metabolit. Den amerikanska antidopnings organisationen USADA meddelade nyheten under torsdagskvällen där de även gick ut med att Taisumov stängs av i 6 månader. Ett straff som ryssen har accepterat.
Mairbek Taisumov Accepts Sanction for Violation of UFC Anti-Doping Policy https://t.co/p8Qfe1C6Rj pic.twitter.com/FuZdAblBYI
— USADA | UFC Anti-Doping Program (@USADA_UFC) April 11, 2019
Kontaminerat kosttillskott
Stanozolol är en syntetisk anabolisk steroid och i vanliga fall skulle Taisumov blivit avstängd i minst 2 år, men ryssen kunde enligt USADA bevisa att han fått i sig ämnet via kontaminerat kosttillskott. Den 30-årige Taisumov redogjorde en lista för USADA med alla kosttillskott som han använde sig och USADA kunde finna spår av stanozolol i både öppna likväl stängda förpackningar av vissa kosttillskott.
Taisumov testade positivt vid en dopningskontroll i samband med hans match mot Desmond Green på UFC Moskva i september förra året. Straffet är retroaktivt vilket innebär att han kan tävla nu om han så önskar.
Nedan kan ni ta del av USADA pressmeddelande kring Taisumovs dopningsfall
USADA announced today that Mairbek Taisumov, of Vienna, Austria, has accepted a six-month sanction for a violation of the UFC® Anti-Doping Policy after testing positive for a prohibited substance.
Taisumov, 30, tested positive for stanozolol metabolites 3′-hydroxystanozolol-O-glucuronide and 16β-hydroxystanozolol-O-glucuronide as the result of an in-competition urine sample he provided on September 15, 2018 at UFC Fight Night in Moscow, Russia. Stanozolol is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
Following notification of his positive test, Taisumov provided USADA with information about dietary supplement products he was using before and at the time of the relevant sample collection. USADA obtained open packages of the dietary supplements and collaborated with the Russian Anti-Doping Agency (RUSADA) to source unopened packages from Russia. Although no prohibited substances were listed on the supplement labels, product analysis conducted on both the open and independently sourced, unopened packages of the products by the WADA-accredited laboratory in Salt Lake City, Utah, indicated that they all contained stanozolol.
The presence of an undisclosed prohibited substance in a product is regarded as contamination. Accordingly, the products have since been added to the list of high-risk supplements maintained on USADA’s online dietary supplement safety education and awareness resource – Supplement 411 (www.Supplement411.org).
Under the UFC Anti-Doping Policy, as well as the World Anti-Doping Code, the determination that an athlete’s positive test was caused by a contaminated product may result in a reduced sanction. Where contamination is established, the sanction for a doping offense involving a non-Specified Substance ranges from a reprimand and no period of ineligibility, at a minimum, to a two-year period of ineligibility, at a maximum.
Here, USADA took into consideration the circumstances that resulted in Taisumov’s positive test and determined that a six-month period of ineligibility was an appropriate sanction under the rules for his violation.
Taisumov’s six-month period of ineligibility began on October 8, 2018, the date his provisional suspension was imposed. Under the rules, any decision concerning competition results is handled by the UFC.
